Skip to main content
SpringerLink
Log in

Should Cardiac Resynchronization Be Considered for the Prevention of Heart Failure?

  • Chapter
Devices for Cardiac Resynchronization

  • 664 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106:2145–2161.

    Article  PubMed  Google Scholar 

  2. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005;46:1116–1143.

    Article  Google Scholar 

  3. Bax JJ, Abraham T, Barold SS, et al. Cardiac resynchronization therapy: Part 1—Issues before device implantation. J Am Coll Cardiol 2005;46:2153–2167.

    Article  PubMed  Google Scholar 

  4. Bax JJ, Abraham T, Barold SS, et al. Cardiac resynchronization therapy: Part 2—Issues during and after device implantation and unresolved questions. J Am Coll Cardiol 2005;46:2168–2182.

    Article  PubMed  Google Scholar 

  5. Hasan A, Abraham WT. Cardiac resynchronization treatment of heart failure. Annu Rev Med 2007; 58–63. Review.

    Google Scholar 

  6. Abraham WT, Fisher WG, Smith AL, et al. MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845–1853.

    Article  PubMed  Google Scholar 

  7. Young JB, Abraham WT, Smith AL, et al. Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003;289:2685–2694.

    Article  PubMed  Google Scholar 

  8. Abraham WT, Young JB, Leon AR, et al. Multicenter InSync ICD II Study Group. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 2004;110:2864–2868.

    Article  PubMed  Google Scholar 

  9. Higgins SL, Hummel JD, Niazi IK, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003;42:1454–1459.

    Article  PubMed  Google Scholar 

  10. Bleeker GB, Schalij MJ, Holman ER, et al. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol 2006;98:230–235.

    Article  PubMed  Google Scholar 

  11. Kindermann M, Hennen B, Jung J, et al. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: The Homburg Biventricular Pacing Evaluation (HOBIPACE). J Am Coll Cardiol 2006;47:1927–1937.

    Article  PubMed  Google Scholar 

  12. Fung JW, Zhang Q, Yip GW, et al. Effect of cardiac resynchronization therapy in patients with moderate left ventricular systolic dysfunction and wide QRS Complex: A prospective study. J Cardiovasc Electrophysiol 2006; 17:1288–1292.

    Article  PubMed  Google Scholar 

  13. Linde C, Gold M, Abraham WT, Daubert J-C, for the REVERSE Study Group. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure—the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Am Heart J 2006;151:288–294.

    Article  PubMed  Google Scholar 

  14. Moss AJ, Brown MW, Cannom DS, et al. Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): Design and clinical protocol. Ann Noninvasive Electrocardiol 2005;10(4 Suppl):34–43.

    Google Scholar 

  15. Barold SS, Lau CP. Primary prevention of heart failure in cardiac pacing. Pacing Clin Electrophysiol 2006; 29:271–219.

    Google Scholar 

  16. Cleland JGF, Daubert J-C, Erdmann E, et al, for the Cardiac Resynchronization—Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352: 1539–1549.

    Article  PubMed  CAS  Google Scholar 

  17. Sweeney MO, Prinzen FW. A new paradigm for physiologic ventricular pacing. J Am Coll Cardiol 2006;47:282–288.

    Article  PubMed  Google Scholar 

  18. Doshi RN, Daoud EG, Fellows C, et al. Left ventricular- based cardiac stimulation post AV nodal ablation evaluation (The PAVE Study). J Cardiovasc Electrophysiol 2005;16:1160–1165.

    Article  PubMed  Google Scholar 

  19. Sweeney MO, Hellkamp AS, Ellenbogen KA, et al, for the MOST Investigators. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;107:2932–2937.

    Article  PubMed  Google Scholar 

  20. Sweeney MO, Hellkamp AS. Heart failure during cardiac pacing. Circulation 2006;113:2082–2088.

    Article  PubMed  Google Scholar 

  21. Tops LF, Schalij MJ, Holman ER, et al. Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation. J Am Coll Cardiol 2006;48:1642–1648.

    Article  PubMed  Google Scholar 

  22. Leon AR, Greenberg JM, Kanuru N, et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: Effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol 2002;39:1258–1263.

    Article  PubMed  Google Scholar 

  23. Horwich T, Foster E, DE Marco T, et al. Effects of resynchronization therapy on cardiac function in pacemaker patients “upgraded” to biventricular devices. J Cardiovasc Electrophysiol 2004;15:1284–1289.

    Article  PubMed  Google Scholar 

  24. Eldadah ZA, Rosen B, Hay I, et al. The benefit of upgrading chronically right ventricle-paced heart failure patients to resynchronization therapy demonstrated by strain rate imaging. Heart Rhythm 2006;3:435–442.

    Article  PubMed  Google Scholar 

  25. Marai I, Gurevitz O, Carasso S, et al. Improvement of congestive heart failure by upgrading of conventional to resynchronization pacemakers. Pacing Clin Electrophysiol 2006;29:880–884.

    Article  PubMed  Google Scholar 

  26. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: Results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002;40:111–118.

    Article  PubMed  Google Scholar 

  27. Baker CM, Christopher TJ, Smith PF, et al. Addition of a left ventricular lead to conventional pacing systems in patients with congestive heart failure: Feasibility, safety, and early results in 60 consecutive patients. PACE 2002;25:1166–1171.

    PubMed  Google Scholar 

  28. Valls-Bertault V, Fatemi M, Gilard M, et al. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation. Europace 2004;6:438–443.

    Article  PubMed  Google Scholar 

  29. Rosen BD, Berger R. Resynchronization therapy upgrade. Turning coach into first class. J Cardiovasc Electrophysiol 2004;15:1290–1292.

    Article  PubMed  Google Scholar 

  30. Hoijer CJ, Meurling C, Brandt J. Upgrade to biventricular pacing in patients with conventional pacemakers and heart failure: A double-blind, randomized crossover study. Europace 2006;8:51–55.

    Article  PubMed  Google Scholar 

  31. Leclercq C, Cazeau S, Lellouche D, et al. Upgrading from right-ventricular pacing to biventricular pacing in previously paced patients with advanced heart failure: A randomized controlled study. Eur Heart J 2003;24(Suppl Aug/Sept):364A.

    Article  Google Scholar 

  32. Bertault V, Fatemi M, Etienne Y, et al. Congestive heart failure in patients with right-ventricular pacing after atrioventricular node ablation. Is upgrading to biventricular pacing an effective treatment. Eur Heart J 2003;24(Suppl Aug/Sept24):521A.

    Article  Google Scholar 

  33. Ritter O, Koller ML, Fey V, et al. Progression of heart failure in right univentricular pacing compared to biventricular pacing. Int J Cardiol 2006;110(3):359–365.

    Article  PubMed  Google Scholar 

  34. Rubaj A, Rucinski P, Rejdak K, et al. Biventricular versus right ventricular pacing decreases immune activation and augments nitric oxide production in patients with chronic heart failure. Eur J Heart Fail 2006; 8:615–620.

    Article  PubMed  CAS  Google Scholar 

  35. Leclercq C, Walker S, Linde C, et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002;23(22):1732–1736.

    Article  Google Scholar 

  36. Thackray SD, Witte KK, Nikitin NP, et al. The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population. Eur Heart J 2003;24:1143–1152.

    Article  PubMed  Google Scholar 

  37. O’Keefe JH Jr, Abuissa H, Jones PG, et al. Effect of chronic right ventricular apical pacing on left ventricular function. Am J Cardiol 2005;95:771–773.

    Article  PubMed  Google Scholar 

  38. Lupi G, Sassone B, Badano L, et al.; Ablate and Pace in Atrial Fibrillation (APAF) Pilot Echocardiographic Trial Investigators. Effects of right ventricular pacing on intra-left ventricular electromechanical activation in patients with native narrow QRS. Am J Cardiol 2006;98(2):219–222.

    Article  PubMed  Google Scholar 

  39. Sweeney MO, Hellkamp AS, Lee KL, Lamas GA; Mode Selection Trial (MOST) Investigators. Association of prolonged QRS duration with death in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2005;111: 2418–2423.

    Article  PubMed  Google Scholar 

  40. Miyoshi F, Kobayashi Y, Itou H, et al. Prolonged paced QRS duration as a predictor for congestive heart failure in patients with right ventricular apical pacing. Pacing Clin Electrophysiol 2005;28:1182–1188.

    Article  PubMed  Google Scholar 

  41. Hayes JJ, Sharma AD, Love JC, et al,; DAVID Investigators. Abnormal conduction increases risk of adverse outcomes from right ventricular pacing. J Am Coll Cardiol 2006;48:1628–1633.

    Article  PubMed  Google Scholar 

  42. Barold SS, Stroobandt RX. Harmful effects of long-term right ventricular pacing. Acta Cardiol 2006;61:103–110.

    Article  PubMed  Google Scholar 

  43. Manolis AS. The deleterious consequences of right ventricular apical pacing: Time to seek alternate site pacing. Pacing Clin Electrophysiol 2006;29:298–315.

    Article  PubMed  Google Scholar 

  44. Barold SS, Herweg B. Right ventricular outflow tract pacing: not ready for prime time. J Interv Card Electrophysiol 2005;13:39–46.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. I. Eli Ovsyshcher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Serge Barold
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Clinical Professor of Medicine, University of South Florida College of Medicine and Division of Cardiology Tampa General Hospital, Tampa, Florida, USA

    S. Serge Barold MD, FRACP, FACP FACC, FESC, FHRS

  2. Chairman, Cardiostim InParys, St Cloud Clinique Bizet, Paris Clinique Chirurgicale Val d’Or, St Cloud, Paris, France

    Philippe Ritter MD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Ovsyshcher, I.E., Barold, S.S. (2008). Should Cardiac Resynchronization Be Considered for the Prevention of Heart Failure?. In: Barold, S.S., Ritter, P. (eds) Devices for Cardiac Resynchronization. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-71167-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-71167-6_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-71166-9

  • Online ISBN: 978-0-387-71167-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation